214 studies found for:    Lymphoma AND (women OR woman OR female)
Show Display Options
Rank Status Study
21 Recruiting Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
Conditions: Aids-related Malignancies;   Lymphoma;   Precancerous Condition;   Sarcoma
Interventions: Genetic: polymerase chain reaction;   Other: cytology specimen collection procedure;   Other: histological technique;   Procedure: colposcopic biopsy
22 Recruiting Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Anemia;   Fever, Sweat, and Hot Flashes;   Stage I Chronic Lymphocytic Leukemia;   Stage I Small Lymphocytic Lymphoma;   Stage II Chronic Lymphocytic Leukemia;   Stage II Small Lymphocytic Lymphoma;   Stage III Chronic Lymphocytic Leukemia;   Stage III Small Lymphocytic Lymphoma;   Stage IV Chronic Lymphocytic Leukemia;   Stage IV Small Lymphocytic Lymphoma;   Weight Change
Interventions: Drug: Ibrutinib;   Drug: Fludarabine Phosphate;   Drug: Cyclophosphamide;   Biological: Rituximab;   Other: Quality-of-Life Assessment;   Other: Laboratory Biomarker Analysis
23 Completed Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma
Condition: Hodgkins Lymphoma
Interventions: Drug: 8 cycles BEACOPPesc plus oral contraceptive;   Drug: 8 cycles BEACOPPesc plus Goserelin
24 Terminated Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation Therapy
Condition: Breast Cancer
Interventions: Procedure: Breast MRI;   Procedure: Mammogram
25 Active, not recruiting
Has Results
Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
Condition: Diffuse Large B-cell Lymphoma
Interventions: Drug: Lenalidomide;   Drug: Gemcitabine;   Drug: Oxaliplatin;   Drug: Rituximab;   Drug: Etoposide
26 Recruiting Lymphoma Bridge Transplant Study
Conditions: Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma
Interventions: Drug: Bendamustine;   Drug: Carmustine;   Drug: Etoposide;   Drug: Melphalan;   Drug: Cytarabine;   Drug: Alemtuzumab;   Biological: Autologous Stem Cell Transplantation;   Biological: Allogeneic Stem Cell Transplantation;   Drug: Rituximab
27 Unknown  Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: cladribine;   Drug: temsirolimus;   Genetic: cytogenetic analysis;   Genetic: gene expression analysis;   Genetic: protein expression analysis;   Other: laboratory biomarker analysis;   Other: liquid chromatography;   Other: mass spectrometry
28 Completed SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Other: biologic sample preservation procedure;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
29 Recruiting Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
Conditions: Stage II Contiguous Adult Diffuse Large Cell Lymphoma;   Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma;   Stage III Adult Diffuse Large Cell Lymphoma;   Stage IV Adult Diffuse Large Cell Lymphoma
Interventions: Drug: Lenalidomide;   Biological: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Drug: Vincristine Sulfate;   Drug: Prednisone;   Other: Laboratory Biomarker Analysis
30 Active, not recruiting Involved Field Radiotherapy for Non-gastric Marginal Zone Lymphoma
Condition: Non-gastric Marginal Zone Lymphoma
Intervention: Radiation: Involved Field Radiotherapy
31 Terminated S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: bendamustine hydrochloride;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: leucovorin calcium;   Drug: methotrexate;   Drug: vincristine sulfate
32 Recruiting Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
Conditions: Lymphoma;   Lymphoproliferative Disorder
Interventions: Other: biologic sample preservation procedure;   Other: informational intervention
33 Completed
Has Results
Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: epratuzumab;   Biological: rituximab;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: vincristine sulfate
34 Completed SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Condition: Lymphoma
Intervention: Other: biologic sample preservation procedure
35 Completed Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: denileukin diftitox;   Biological: rituximab;   Other: flow cytometry;   Other: immunoenzyme technique;   Other: laboratory biomarker analysis
36 Active, not recruiting S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Biological: tositumomab;   Drug: cyclophosphamide;   Drug: doxorubicin;   Drug: prednisone;   Drug: vincristine;   Radiation: tositumomab
37 Active, not recruiting CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma
Condition: T-cell Non-Hodgkin Lymphoma
Interventions: Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Etoposide;   Drug: Prednisone;   Drug: Filgrastim;   Drug: Plerixafor;   Procedure: Stem Cell Collection;   Drug: Palifermin;   Drug: Gemcitabine;   Drug: Busulfan;   Drug: Melphalan;   Procedure: Stem Cell Transplant
38 Active, not recruiting
Has Results
S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: bortezomib;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: vincristine sulfate
39 Completed
Has Results
Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
Condition: Lymphoma
Interventions: Biological: epratuzumab;   Biological: rituximab
40 Recruiting Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell Lymphoma
Conditions: Relapsed or Refractory Hodgkin Lymphoma;   Primary Mediastinal Large B-cell Lymphoma
Intervention: Drug: Ruxolitinib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years